ANTIBIOTICE
84 articole · RSS
Antibiotice Iasi Plans to Double Exports and Revenue Starting 2020
Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, plans to double exports abroad soon, which would double its revenue.
Antibiotice CEO Ioan Nani Plans to Double Salaries at His Company in Five Years
The ambition of Ioan Nani, CEO of pharmaceutical producer Antibiotice Iasi and one of the longest-standing executives in local pharmaceutical industry is too boost sales and profitability ov...
Antibiotice Iasi to Double Production of Creams and Ointments by 2020
Pharmaceutical producer Antibiotice Iasi’s investment in its new topical product (such as creams, lotions and ointments) plant will amount to EUR20 million and will be completed by the end o...
Antibiotice To Open Offices In Kiev And Chisinau
Pharmaceutical company Antibiotice (ATB.RO) reached its targets last year and will continue development by consolidating presence on international markets this year, says CEO Ioan Nani.
Antibiotice Iasi Posts Higher Profit, Of RON19.19M, In 1H/2017
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Thursday reported a profit of RON19.19 million in January-June 2017, higher than RON16.4 million in the year-earlier period, accordi...
Antibiotice Iasi To Boost Production Of Creams, Ointments And Gels
A number of 60 million drug packs leave the plant of pharmaceutical producer Antibiotice Iasi annually, 35% to 40% of which topical products (creams, ointments, gels), says chief executive I...
Antibiotice Iasi Seeks RON30M Loan From UniCredit Bank
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) has called a shareholders' meeting for August 11 to approve the contracting of a RON30 million (EUR6.7 million) loan from a UniCredit B...
Antibiotice Iasi Exported $3.4M Worth Of Injectable Drugs To U.S. This Year
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) in June finished the delivery of a $3.4 million order for injectable medicines to the United States.
Antibiotice Iasi 1Q Turnover Up 5% To RON55.1M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a turnover of RON55.1 million in the first quarter of 2016, up 5% from RON52.6 million in the year-earlier period and 1% highe...